Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous Antibiotics for PJI
NCT03713528Phase 4Enrolling by invitation
- Sponsor
- OrthoCarolina Research Institute
- Start
- Jan 2020
- Primary completion
- Jan 2027
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of vancomycin in periprosthetic joint infection (PJI), sponsored by OrthoCarolina Research Institute. Primary endpoint: Recurrence of Infection at 1 year. Started Jan 2020; status: enrolling by invitation.
02
Drugs
vancomycin
03
Conditions
periprosthetic joint infection (PJI)
Beyond the preview
Go deeper on NCT03713528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03713528.